HIV-associated dementia (HAD) is a neurocognitive disorder that can affect individuals with HIV/AIDS. Unlike Alzheimer's disease, which primarily affects older adults and involves progressive cognitive decline, HAD is linked to the presence of HIV in the central nervous system. It often presents with symptoms such as memory loss, confusion, motor deficits, and behavioral changes. The underlying mechanisms involve HIV's ability to infect brain cells and trigger inflammation, leading to neuronal damage. Treatment focuses on managing HIV infection with antiretroviral therapy (ART), which can improve neurological symptoms and prevent progression. Unlike Alzheimer's, HAD primarily targets younger populations and underscores the importance of early HIV detection and treatment to mitigate neurological complications.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States